Clinical Trial Update: Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines [EARLY_Phase 1]

View source ↗

Summary

Phase 1 translational study evaluating 18F-labeled hydroxyphenethylguanidines for autonomic nervous system diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Nervous System Disorders

Drugs mentioned

• 18F-labeled hydroxyphenethylguanidines (18F-labeled hydroxyphenethylguanidine tracer)

Snippet

Sponsor: University of Michigan | Conditions: Autonomic Peripheral Nervous System Diseases | EARLY_Phase 1 | Status: COMPLETED